ELOCP33

Across TCGA pan-cancer cohorts, ELOCP33 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of ELOCP33’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where ELOCP33 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ELOCP33 is over-expressed in tumor, although a few such as LUAD show the opposite, repressed pattern.

BRCA, LIHC, and LUAD are the cancer types where ELOCP33 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ELOCP33 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	All	+0.137	.044	2	view →
LIHC	All	III,IV	+0.032	.032	2	view →
LUAD	All	III,IV	−0.072	.044	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

ELOCP33–BRCA

Open the BRCA breakdown →